, Tracking Stock Market Picks
Enter Symbol:
Oncolytics Biotech, Inc. (ONCY) [hlAlert]

down 81.46 %

Oncolytics Biotech, Inc. (ONCY) rated Buy with price target $6 by Stifel Nicolaus

Posted on: Thursday,  Aug 30, 2012  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Oncolytics Biotech, Inc. (NASDAQ: ONCY) on 08/30/2012, when the stock price was $2.86. Since
then, Oncolytics Biotech, Inc. has lost 81.47% as of 11/04/2015's recent price of $0.53.
If you would have followed this Stifel Nicolaus's recommendation on ONCY, you would have lost 81.46% of your investment in 1161 days.

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/30/2012 8:25 AM Buy
2.86 6.00
as of 12/31/2012
1 Week up  9.80 %
1 Month up  64.01 %
3 Months up  68.24 %
1 YTD up  37.06 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy